Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population

Summary

This is a randomized, double-blind, positive controlled design clinical trial of tetanus vaccine, adsorbed manufactured by Sinovac Life Sciences Co., Ltd.The purpose of this study is to evaluate the safety and immunogenicity of tetanus vaccine, adsorbed in 18\~44 years old population.

Timeline

Start

2023-09-01

Primary completion

2023-10-26

Completion

2024-03-22

Drugs

Indications